Evaluating the Diagnostic Utility of 16S Oxford Nanopore Technology Sequencing in Patients With Central Nervous System Infections and Its Usefulness in Antimicrobial Stewardship - Takeaways - MDSpire

Evaluating the Diagnostic Utility of 16S Oxford Nanopore Technology Sequencing in Patients With Central Nervous System Infections and Its Usefulness in Antimicrobial Stewardship

  • By

  • Do Van Dong

  • Le Thi Kieu Linh

  • Nguyen Thi Tuyet Nga

  • Nghiem Xuan Hoan

  • Nguyen Thi Khanh Linh

  • Tran Thi Thanh Huyen

  • Hoang Xuan Quang

  • Tran Thi Lien

  • Van Dinh Trang

  • Vu Viet Sang

  • Peter G Kremsner

  • Le Huu Song

  • Dennis Nurjadi

  • Thirumalaisamy P Velavan

  • May 26, 2025

  • 0 min

Share

  • 1

    The study evaluated the diagnostic efficacy of 16S Oxford Nanopore Technology sequencing for CNS infections compared to traditional CSF culture methods.

  • 2

    A total of 329 patients were analyzed, with 40 samples testing positive for pathogens; 16S ONT detected 28, while CSF culture identified 23.

  • 3

    16S ONT sequencing identified 17 pathogens not detected by CSF culture, highlighting its superior sensitivity and diagnostic yield.

  • 4

    Based on 16S ONT findings, 61% of patients received inappropriate empirical antibiotic therapy, indicating a need for improved antimicrobial management.

  • 5

    The study emphasizes the potential of 16S ONT sequencing to enhance antimicrobial stewardship and improve patient outcomes in resource-limited settings.

Original Source(s)

Related Content